Acute Pancreatitis News and Research

RSS
Acute pancreatitis is a sudden inflammation of the pancreas. Depending on its severity, it can have severe complications and high mortality despite treatment. While mild cases are often successfully treated with conservative measures, such as NPO (nil by mouth or NBM) and IV fluid rehydration, severe cases may require admission to the ICU or even surgery (often requiring more than one intervention) to deal with complications of the disease process.
FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

FDA approves GSK's Tanzeum as once-weekly treatment for type 2 diabetes

Mayo Clinic collaborates with Enterprise Ireland to advance novel medical technologies

Mayo Clinic collaborates with Enterprise Ireland to advance novel medical technologies

Researchers find link between acute pancreatitis and pancreatic cancer

Researchers find link between acute pancreatitis and pancreatic cancer

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Leukemia drug reverses symptoms of colitis in lab tests

Leukemia drug reverses symptoms of colitis in lab tests

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

Endoscopic ultrasound-guided drainage improves outcomes in patients with pseudocysts

Updated guidelines for management of acute pancreatitis

Updated guidelines for management of acute pancreatitis

Scientists provide proof of principle for drug-based treatment of acute pancreatitis

Scientists provide proof of principle for drug-based treatment of acute pancreatitis

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Patients with type2 diabetes, renal impairment have less hypoglycemia with JANUVIA compared to sulfonylurea

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Special issue of Gastroenterology presents variety of topics related to pancreas

Special issue of Gastroenterology presents variety of topics related to pancreas

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Pancreatitis and diabetes drugs: an interview with Dr Sonal Singh, Johns Hopkins University School of Medicine

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

Merck, Pfizer sign collaboration agreement for development and commercialization of ertugliflozin

New study associates commonly used diabetes drugs with pancreatic cancer risk

New study associates commonly used diabetes drugs with pancreatic cancer risk

GLP-1 pancreatitis concerns justified

GLP-1 pancreatitis concerns justified

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Five prominent surgeons receive Honorary Fellowship from ACS

Five prominent surgeons receive Honorary Fellowship from ACS

NFAT protein plays a part in development of acute pancreatitis

NFAT protein plays a part in development of acute pancreatitis